New York-Presbyterian Hospital New York Study Aims to Assess Utility of Clinical Whole-Genome Sequencing Across Diseases Premium Over the next year or so, the investigators plan to sequence the genomes of 3,000 patients with cancer, heart disease, diabetes, or neurological disorders. Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing Weill Cornell Medicine, New York-Presbyterian Hospital, and the New York Genome Center will join Illumina to sequence the genomes of thousands of patients. Weill Cornell Integrates Cancer Exome Test Into EHRs With Eye Toward Next Version Premium After three years of work, the EXaCT-1 exome cancer test has become part of clinical cancer care at NewYork-Presbyterian, but developers have higher ambitions. Biotia Aims to Cut Hospital-Acquired Infections by Monitoring Microbiome of Hospital Environment Premium The company hopes to raise funding this summer and has been conducting pilots with NewYork-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center. Columbia U, Life Raft Use Pathway Approach to Find New Therapies for Resistant GI Tumors Premium The partners aim to identify master regulators in the molecular networks of GIST patients that can serve as drug targets for existing treatments. Jul 20, 2016 Weill Cornell Medicine to Expand Tumor Exome Test to Thousands of Advanced Cancer Patients Premium Jul 15, 2016 Columbia, New York-Presbyterian Land $58.4M NIH Grant for Personalized Medicine Jan 31, 2013 Weill Cornell, New York-Presbyterian Launch Clinical Genomics Institute May 5, 2010 Researchers Identify Gene Variants That Protect Against Colorectal Cancer with Statin Use Premium Breaking News Analysis Finds Sibling Cascade Testing Could Be Cost Effective in Pediatric Cancer Armonica Technologies Closes $2M Series B Financing Round Top Five Articles on GenomeWeb Last Week: SARS-CoV-2 PCR Tests; California Cancer Testing Law; More In Brief This Week: The Jackson Laboratory, CareDx, Merck Global Health Innovation Fund, and More People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More New Products Posted to GenomeWeb: NanoString, Sophia Genetics, EliTech, Lybe Scientific, More The Scan J&J Booster Support A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times. To Keep the Cases Moving The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases. NAS Expels Archaeologist Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences. PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.